OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit www.conferenceseries.com

Back

Feng Tao

Feng Tao

Assistant Professor
Department of Anesthesiology and Critical Care Medicine
Johns Hopkins University School of Medicine
USA

Biography

Feng Tao has completed his Ph.D in 2000 and postdoctoral training in 2005. Currently he is an Assistant Professor in the Department of Anesthesiology and Critical Care Medicine at Johns Hopkins University School of Medicine. Dr. Tao received his RO1 award from NIH in 2012. He has published 30 papers in peer-reviewed professional journals and he is serving as an editorial board member for several professional journals. Dr. Tao also served as an invited reviewer for Johns Hopkins ACCM Seed Grant, NSF-sponsored Pilot Funding at Louisiana State University, and Wings for Life−Spinal Cord Research Foundation in Austria.

Research

Feng Tao’s research interests focus on the central mechanisms of analgesia and anesthesia. The goal of his work is to understand how the effects of analgesics and anesthetics on their neuronal targets are regulated. Specifically, he is interested in the regulation of central sensitization mediated by glutamate receptors and their interacting proteins. It is through these pathways that pain sensation is modulated in the central nervous system, especially at the spinal cord level. As an extension of his pain research, Dr. Tao has begun a collaboration with other investigators at Johns Hopkins to address the problems of central chronic pain after spinal cord injury using a unique stem cell approach. This research project has been funded by a Maryland Stem Cell Research Grant. In 2012, he developed a new line of research to investigate stress-induced pain transition after surgery and this research proposal has been funded with a 5-year NIH R01 grant.